Insider Transactions in Q3 2025 at Collegium Pharmaceutical, Inc (COLL)
Insider Transaction List (Q3 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Aug 13
2025
|
Scott Dreyer EVP & Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
4,861
-4.48%
|
$184,718
$38.03 P/Share
|
|
Aug 13
2025
|
Scott Dreyer EVP & Chief Commercial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
4,861
+4.29%
|
$102,081
$21.34 P/Share
|
|
Aug 13
2025
|
Rubric Capital Management LP > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
25,000
-0.79%
|
$925,000
$37.85 P/Share
|
|
Aug 08
2025
|
John Gordon Freund Director |
SELL
Open market or private sale
|
Indirect |
11,659
-33.51%
|
$396,406
$34.36 P/Share
|